Abstract
The Tohoku earthquake off the Pacific coast in March 2011 led to massive medical requirements. Although the availability of drugs is essential in the disaster-affected area, a shortage of drugs and a lack of supply of drugs were reported. Moreover, in Japan, there are concerns regarding the occurrence of a large-scale earthquake, such as the Nankai Trough megathrust earthquake, in the near future. Therefore, drug requirements in a disaster-affected area need to be determined in advance. This study uses national health insurance data (KDB), which are medical big data, to determine the drug requirements in the region from insurance claim information. This study focuses on epilepsy as the target disease and determines the quantity and quality of antiepileptic drugs required in the region via analysis.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
